Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China

Table 2

HIV-related characteristics at admission.

Variables	Statistic value
Receiving ART (n, %)	38 (79.2%)
time since ART initiation (years, median, and IQR)	4 (2–9)
History of opportunistic infections (n, %)	9 (18.8%)
Syphilis (n, %)	16 (33.3%)
HCV (n, %)	3 (6.3%)
CD4 cell counts before ACS (cells/μl, median, and IQR)	365 (182–631)
VL before ACS (copies/ml, median, and IQR)	<40 (<40–37633)
^aART drugs (n, %)
NRTIs	18 (47.4%)
NNRTIs	12 (31.6%)
PIs	6 (15.8%)
Unknown	2 (5.3%)

The symbol indicates that 38 patients were included receiving ART; the symbol indicates that the CD4 cell count was only available in 31 patients; the symbol indicates thatVL was only available in 26 patients. ART: antiretroviral therapy; IQR: interquartile range; HCV: hepatitis C virus; ACS: acute coronary syndrome; VL: HIV load; NNRTIs: non-nucleoside reverse transcriptase inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; PIs: protease inhibitors.